Marshall Randall 4
4 · Protara Therapeutics, Inc. · Filed Jul 31, 2020
Insider Transaction Report
Form 4
Marshall Randall
10% Owner
Transactions
- Sale
Common Stock
2020-07-29$27.28/sh−600$16,368→ 612,597 total - Sale
Common Stock
2020-07-29$28.45/sh−100$2,845→ 612,497 total - Sale
Common Stock
2020-07-30$26.14/sh−1,317$34,426→ 611,180 total - Sale
Common Stock
2020-07-29$26.03/sh−1,816$47,270→ 613,197 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.35, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.02 to $27.83, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.525, inclusive.